Stock ALK ALKEMY S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Alkemy S.p.A.

Equities

ALK

IT0005314635

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-05-02 am EDT 		5-day change 1st Jan Change
10.35 EUR -0.96% Intraday chart for Alkemy S.p.A. -1.90% +12.62%
Apr. 23 Futures up; wait for Eurozone PMI AN
Apr. 22 Mib bearish; DiaSorin closes ahead of all AN

Strengths

  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • The company shows low valuation levels, with an enterprise value at 0.68 times its sales.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Ratings chart - Surperformance

Sector: Advertising & Marketing

1st Jan change Capi. Investor Rating ESG Refinitiv
ALKEMY S.P.A. Stock Alkemy S.p.A.
+12.62% 61.75M -
DATA COMMUNICATIONS MANAGEMENT CORP. Stock DATA Communications Management Corp.
+16.41% 123M -
DMS INC. Stock DMS Inc.
-3.06% 64.38M - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. ALK Stock
  4. Ratings Alkemy S.p.A.